These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8413420)

  • 1. Screening for colorectal cancer.
    Allison JE
    N Engl J Med; 1993 Oct; 329(18):1352; author reply 1353-4. PubMed ID: 8413420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for colorectal cancer.
    Brown ML
    N Engl J Med; 1993 Oct; 329(18):1352-3. PubMed ID: 8292163
    [No Abstract]   [Full Text] [Related]  

  • 4. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

  • 6. [Economic evaluation of colorectal cancer screening with fecal occult blood detection].
    Maté Jiménez J
    Rev Esp Enferm Dig; 2000 Nov; 92(11):764-5. PubMed ID: 11468859
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 9. Colorectal cancer screening.
    Cher DJ
    J Public Health Med; 1993 Jun; 15(2):211-2. PubMed ID: 8353013
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer.
    Brock G; Gurekas V
    CMAJ; 2001 Apr; 164(7):966; author reply 967-8. PubMed ID: 11314445
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for colorectal cancer.
    Budenholzer B
    CMAJ; 2001 Apr; 164(7):965-6; author reply 967-8. PubMed ID: 11314442
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
    Yamamoto M; Nakama H
    Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
    Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
    J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer. Which test is best?
    Cahill BA
    Adv Nurse Pract; 2005 Jan; 13(1):71-4. PubMed ID: 15679298
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme.
    Ward N; Wright J; Marsh S; Norton J
    Colorectal Dis; 2007 Mar; 9(3):258-61. PubMed ID: 17298625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Screening for colorectal cancer: definitely implement].
    Jansen JB
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1776. PubMed ID: 18754309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of colorectal cancer screening with fecal occult blood detection.
    Tárraga López PJ; Marín Nieto E; Celada Rodríguez A; García Molinero MJ; García Olmo D; Solera Albero J
    Rev Esp Enferm Dig; 2000 May; 92(5):334-48. PubMed ID: 10927933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.